About
Explore Cell Therapies

About Cell Therapies

Our Facility

View our Services

Partnerships and Collaborations

Careers at Cell Therapies

Contact us

Since 2003, Cell Therapies has manufactured cell therapies, ex vivo gene therapies, and regenerative medicine products under GMP standards to meet global regulatory requirements.

Learn about Cell Therapies
Services
Explore Services

Contract Manufacturing

Technology Transfer

Process Development

Analytical Testing and Development

Quality as a Service

Consulting and Advisory

Clinical Trial Support

Cryopreservation & Logistics

Digitalization & Automation

With over two decades of experience in GMP manufacturing of cell-based products, Cell Therapies is a trusted partner in transforming promising research into scalable, compliant, and commercially viable therapies.

Learn about Our Services
Facility
Careers
Explore Careers

Careers at Cell Therapies

View Current Opportunities

Upload your Resume

We are always on the lookout for curious minds, problem-solvers, and biotech enthusiasts to join our team. If you have a background in GMP manufacturing, QC, QA, engineering, or cell and gene therapy development, we would love to hear from you.

Find out about a career at Cell Therapies
News and Resources
Explore News and Resources

All News and Resources

News

Resources

Filter
All News
Resources

ACTRIS Signs MoU with Cell Therapies Pty Ltd to Advance CDMO Capabilities for Cell and Gene Therapies
ACTRIS Signs MoU with Cell Therapies Pty Ltd to Advance CDMO Capabilities for Cell and Gene Therapies
Read More

Cell Therapies and ENCell Forge Strategic APAC Partnership to Advance Cell and Gene Therapy Manufacturing
Cell Therapies and ENCell Forge Strategic APAC Partnership to Advance Cell and Gene Therapy Manufacturing
Read More

A-SEEDS and Cell Therapies Announce Manufacturing Partnership to Advance Clinical Trials of Novel CAR-T Cell Therapy
A-SEEDS and Cell Therapies Announce Manufacturing Partnership to Advance Clinical Trials of Novel CAR-T Cell Therapy
Read More

Read the latest from Cell Therapies
Contact

News

Arovella Therapeutics partners with Cell Therapies to develop its ALA-101 manufacturing process for cancer clinical trials

Cell Therapies Pty Ltd is partnering with Arovella Therapeutics (ASX: ALA) to develop the manufacturing…

Cell TherapiesNovember 8, 2023

Resources

From Concept to Commercialisation: Why the selection of an organisation for a cell and gene therapies can impact your patient outcomes and competitive advantage

The development pipeline of cell and gene therapies faces numerous obstacles while striving for the…

Cell TherapiesAugust 14, 2023

News

Cell Therapies Pty Ltd is delighted to announce the appointment of Dr Bev Menner as the company’s new Chief Executive Officer.

Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the…

Cell TherapiesJuly 26, 2023

News

New commercial-scale cell and gene therapy manufacturing facility for APAC market supply

Cell Therapies Pty Ltd. is excited to announce the opening of new cell and gene…

Cell TherapiesJuly 25, 2023

Resources

Translating innovative cell therapies: What is GMP?

The cell therapy sector is growing rapidly and within it, cell-based therapies derived from human…

Cell TherapiesMay 22, 2023

Resources

Why Australia should be your choice for CGT development

The development of cell and gene therapy is rapidly growing in our industry with a…

Cell TherapiesFebruary 22, 2023

News

Cell Therapies to manufacture BioNTech’s product candidate BNT211 in Australia

Cell Therapies Pty Ltd (CTPL) has been engaged by Germany-based biopharmaceutical company BioNTech SE (BioNTech)…

Cell TherapiesSeptember 21, 2022

News

Cell Therapies Joins Australia’s Cell & Gene Catalyst Steering Group

We are delighted to be part of the Steering Group to lead Australia’s Cell and…

Cell TherapiesAugust 3, 2022

News

Carina Biotech partners with Cell Therapies to deliver a first-in-human CAR-T cell therapy trial to treat colorectal patients

Cell Therapies is partnering with Carina Biotech, a leading Australian immuno-oncology company, to manufacture their…

Cell TherapiesMay 31, 2022

News

Former Cell Therapies’ Chair appointed as Victoria’s New Lieutenant-Governor

Professor James Angus has been appointed the new Lieutenant-Governor of Victoria by Her Excellency the…

Cell TherapiesNovember 15, 2021

News

RM Catalyst consortium reports reveal Australia’s potential

The RM Catalyst consortium recently published two reports revealing Australia's potential to become a global…

Cell TherapiesNovember 11, 2021

News

Announcement from the Chair of the Cell Therapies Board

The Board of Directors of Cell Therapies Pty Ltd is delighted to announce that Ms. Michelle…

Cell TherapiesOctober 13, 2021

Filter

ACTRIS Signs MoU with Cell Therapies Pty Ltd to Advance CDMO Capabilities for Cell and Gene Therapies

Cell Therapies and ENCell Forge Strategic APAC Partnership to Advance Cell and Gene Therapy Manufacturing

A-SEEDS and Cell Therapies Announce Manufacturing Partnership to Advance Clinical Trials of Novel CAR-T Cell Therapy

News and Resources

The latest news and insights from Cell Therapies

Arovella Therapeutics partners with Cell Therapies to develop its ALA-101 manufacturing process for cancer clinical trials

From Concept to Commercialisation: Why the selection of an organisation for a cell and gene therapies can impact your patient outcomes and competitive advantage

Cell Therapies Pty Ltd is delighted to announce the appointment of Dr Bev Menner as the company’s new Chief Executive Officer.

New commercial-scale cell and gene therapy manufacturing facility for APAC market supply

Translating innovative cell therapies: What is GMP?

Why Australia should be your choice for CGT development

Cell Therapies to manufacture BioNTech’s product candidate BNT211 in Australia

Cell Therapies Joins Australia’s Cell & Gene Catalyst Steering Group

Carina Biotech partners with Cell Therapies to deliver a first-in-human CAR-T cell therapy trial to treat colorectal patients

Former Cell Therapies’ Chair appointed as Victoria’s New Lieutenant-Governor

RM Catalyst consortium reports reveal Australia’s potential

Announcement from the Chair of the Cell Therapies Board

Unrivalled experience and service from a global leader in cell and gene therapy manufacturing

Services

Helpful Links

Corporate